NVS logo

Novartis AG (NVS) Short term debt

Annual short term debt:

$8.32B+$2.01B(+31.83%)
December 31, 2024

Summary

  • As of today (September 13, 2025), NVS annual short term debt is $8.32 billion, with the most recent change of +$2.01 billion (+31.83%) on December 31, 2024.
  • During the last 3 years, NVS annual short term debt has risen by +$1.82 billion (+28.02%).
  • NVS annual short term debt is now -15.72% below its all-time high of $9.88 billion, reached on December 31, 2020.

Performance

NVS Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSbalance sheet metrics

quarterly short term debt:

$8.57B+$529.99M(+6.59%)
June 30, 2025

Summary

  • As of today (September 13, 2025), NVS quarterly short term debt is $8.57 billion, with the most recent change of +$529.99 million (+6.59%) on June 30, 2025.
  • Over the past year, NVS quarterly short term debt has increased by +$808.99 million (+10.42%).
  • NVS quarterly short term debt is now -48.30% below its all-time high of $16.58 billion, reached on March 31, 2011.

Performance

NVS quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

NVS Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+31.8%+10.4%
3 y3 years+28.0%+17.4%
5 y5 years+17.4%-6.1%

NVS Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+35.9%at high+51.3%
5 y5-year-15.7%+35.9%-17.9%+51.3%
alltimeall time-15.7%+256.9%-48.3%+266.2%

NVS Short term debt History

DateAnnualQuarterly
Jun 2025
-
$8.57B(+6.6%)
Mar 2025
-
$8.04B(-3.4%)
Dec 2024
$8.32B(+31.8%)
$8.32B(+22.2%)
Sep 2024
-
$6.81B(-12.2%)
Jun 2024
-
$7.76B(-9.3%)
Mar 2024
-
$8.56B(+35.6%)
Dec 2023
$6.31B(+3.1%)
$6.31B(+11.4%)
Sep 2023
-
$5.67B(-33.6%)
Jun 2023
-
$8.54B(+18.2%)
Mar 2023
-
$7.22B(+17.8%)
Dec 2022
$6.13B(-5.8%)
$6.13B(-16.1%)
Sep 2022
-
$7.30B(0.0%)
Jun 2022
-
$7.30B(+4.8%)
Mar 2022
-
$6.97B(+7.2%)
Dec 2021
$6.50B(-34.2%)
$6.50B(-32.4%)
Sep 2021
-
$9.61B(+2.8%)
Jun 2021
-
$9.35B(-10.4%)
Mar 2021
-
$10.44B(+5.7%)
Dec 2020
$9.88B(+39.3%)
$9.88B(-1.2%)
Sep 2020
-
$9.99B(+9.4%)
Jun 2020
-
$9.13B(-18.5%)
Mar 2020
-
$11.21B(+58.0%)
Dec 2019
$7.09B(-26.3%)
$7.09B(-14.4%)
Sep 2019
-
$8.28B(+1.6%)
Jun 2019
-
$8.15B(+5.8%)
Mar 2019
-
$7.70B(-19.9%)
Dec 2018
$9.62B(+85.0%)
$9.62B(+4.8%)
Sep 2018
-
$9.18B(-4.4%)
Jun 2018
-
$9.60B(-12.1%)
Mar 2018
-
$10.91B(+109.8%)
Dec 2017
$5.20B(-11.9%)
$5.20B(-25.7%)
Sep 2017
-
$7.00B(-7.5%)
Jun 2017
-
$7.56B(-9.2%)
Mar 2017
-
$8.32B(+41.0%)
Dec 2016
$5.91B(+5.4%)
$5.91B(-28.9%)
Sep 2016
-
$8.31B(-17.7%)
Jun 2016
-
$10.09B(-13.2%)
Mar 2016
-
$11.63B(+107.5%)
Dec 2015
$5.60B(-14.6%)
$5.60B(-39.7%)
Sep 2015
-
$9.29B(-6.9%)
Jun 2015
-
$9.97B(-3.0%)
Mar 2015
-
$10.28B(+55.5%)
Dec 2014
$6.56B(-1.7%)
$6.61B(-4.7%)
Sep 2014
-
$6.94B(-8.2%)
Jun 2014
-
$7.56B(+25.7%)
Mar 2014
-
$6.01B(-10.0%)
Dec 2013
$6.67B(+12.2%)
$6.67B(-12.8%)
Sep 2013
-
$7.66B(+5.5%)
Jun 2013
-
$7.26B(-22.3%)
Mar 2013
-
$9.33B(+57.0%)
DateAnnualQuarterly
Dec 2012
$5.95B(-6.7%)
$5.95B(+18.5%)
Sep 2012
-
$5.02B(-43.5%)
Jun 2012
-
$8.88B(-17.0%)
Mar 2012
-
$10.70B(+67.8%)
Dec 2011
$6.37B(-26.3%)
$6.37B(-37.2%)
Sep 2011
-
$10.15B(-25.2%)
Jun 2011
-
$13.58B(-18.1%)
Mar 2011
-
$16.58B(+91.8%)
Dec 2010
$8.65B(+62.7%)
$8.65B(-31.5%)
Sep 2010
-
$12.63B(-4.6%)
Jun 2010
-
$13.23B(+195.2%)
Mar 2010
-
$4.48B(-15.6%)
Dec 2009
$5.31B(+2.4%)
$5.31B(-6.0%)
Sep 2009
-
$5.65B(+21.8%)
Jun 2009
-
$4.64B(+2.8%)
Mar 2009
-
$4.51B(-13.0%)
Dec 2008
$5.19B(+1.3%)
$5.19B(-39.3%)
Sep 2008
-
$8.54B(-0.2%)
Jun 2008
-
$8.56B(+21.2%)
Mar 2008
-
$7.06B(+37.9%)
Dec 2007
$5.12B(-23.0%)
$5.12B(-22.2%)
Sep 2007
-
$6.58B(-3.9%)
Jun 2007
-
$6.84B(+3.0%)
Mar 2007
-
$6.65B(+0.0%)
Dec 2006
$6.64B(-6.9%)
$6.64B(-8.2%)
Sep 2006
-
$7.24B(-8.0%)
Jun 2006
-
$7.86B(+17.0%)
Mar 2006
-
$6.72B(-5.9%)
Dec 2005
$7.13B(+72.8%)
$7.13B(+59.0%)
Sep 2005
-
$4.49B(-13.7%)
Jun 2005
-
$5.20B(+49.9%)
Mar 2005
-
$3.47B(-16.0%)
Dec 2004
$4.13B(+48.2%)
$4.13B(+58.3%)
Sep 2004
-
$2.61B(-9.5%)
Jun 2004
-
$2.88B(-15.2%)
Mar 2004
-
$3.40B(+22.0%)
Dec 2003
$2.79B(-3.4%)
$2.79B(-3.4%)
Dec 2002
$2.88B(-5.6%)
$2.88B(-13.6%)
Sep 2002
-
$3.34B(-2.8%)
Jun 2002
-
$3.44B(+12.4%)
Dec 2001
$3.06B(+31.0%)
$3.06B(+3.7%)
Jun 2001
-
$2.95B(+25.9%)
Dec 2000
$2.33B(-50.1%)
$2.34B(-36.3%)
Jun 2000
-
$3.67B
Dec 1999
$4.67B(+11.8%)
-
Dec 1998
$4.18B(-18.3%)
-
Dec 1997
$5.12B(-5.4%)
-
Dec 1996
$5.41B(+0.9%)
-
Dec 1995
$5.36B(-22.1%)
-
Dec 1994
$6.88B(+59.6%)
-
Dec 1993
$4.31B
-

FAQ

  • What is Novartis AG annual short term debt?
  • What is the all time high annual short term debt for Novartis AG?
  • What is Novartis AG annual short term debt year-on-year change?
  • What is Novartis AG quarterly short term debt?
  • What is the all time high quarterly short term debt for Novartis AG?
  • What is Novartis AG quarterly short term debt year-on-year change?

What is Novartis AG annual short term debt?

The current annual short term debt of NVS is $8.32B

What is the all time high annual short term debt for Novartis AG?

Novartis AG all-time high annual short term debt is $9.88B

What is Novartis AG annual short term debt year-on-year change?

Over the past year, NVS annual short term debt has changed by +$2.01B (+31.83%)

What is Novartis AG quarterly short term debt?

The current quarterly short term debt of NVS is $8.57B

What is the all time high quarterly short term debt for Novartis AG?

Novartis AG all-time high quarterly short term debt is $16.58B

What is Novartis AG quarterly short term debt year-on-year change?

Over the past year, NVS quarterly short term debt has changed by +$808.99M (+10.42%)
On this page